Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05555875 · ClinicalTrials.gov registry record · NA

Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part II

A NA study of Depression and Anxiety Disorders, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
NA
Development phase
76
Enrollment target
1
Study location

NCT05555875 is a NA study of Depression and Anxiety Disorders that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 76 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05555875, a NA study of Depression and Anxiety Disorders, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
NA
Development phase
76 participants
Enrollment target
1
Study location

Study Summary

This study is a clinical trial that evaluates what drives patient engagement and tests the impact of two strategies-automated motivational push messaging and coach support-to improve engagement with an evidence-based mobile app intervention for depression and/or anxiety.

Interventions

  • BEHAVIORAL IntelliCare Plus

Study Locations (1)

Massachusetts

  • Jessica Morrow Lipschitz - Boston

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2023-06-07
Est. Completion 2025-07-20
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT05555875

The ClinicalTrials.gov registry entry for NCT05555875 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (90% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which IntelliCare Plus is the first listed.

NCT05555875 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05555875 about?

NCT05555875 is a clinical study titled "Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part II". This study is a clinical trial that evaluates what drives patient engagement and tests the impact of two strategies-automated motivational push messaging and coach support-to improve engagement with an evidence-based mobile app intervention for depression and/or anxiety.

What is the current status of trial NCT05555875?

This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2023-06-07. Estimated completion is 2025-07-20.

What conditions does trial NCT05555875 study?

This clinical trial studies the following conditions: Depression, Anxiety Disorders.

What interventions are being tested in trial NCT05555875?

The interventions under investigation include: IntelliCare Plus (BEHAVIORAL).

Who is sponsoring clinical trial NCT05555875?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05555875 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.